Literature DB >> 235500

A study of the anticholinergic and antispasmodic activity of oxybutynin (Ditropan) on rabbit detrusor.

C M Fredericks, G F Anderson, D L Kreulen.   

Abstract

Experiments have been conducted which show that while the tertiary amine oxybutynin has only moderate in vitro anticholinergic and antihistaminic activity, it is a potent inhibitor of barium chloride-induced spasms of rabbit detrusor muscle. Oxybutynin exerts 1/13 the anticholinergic activity of propantheline and 1/4 that of atropine, but produces approximately 2x the inhibition of barium chloride-induced spasm than propantheline and 10x the inhibition produced by atropine. In sum, oxybutynin possesses a notable antispasmodic activity distinct from its anticholinergic activity and stronger than that of atropine, propantheline, or methantheline, which may prove useful in the treatment of smooth muscle hypermotility.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 235500

Source DB:  PubMed          Journal:  Invest Urol        ISSN: 0021-0005


  3 in total

1.  Differences in the effects of urinary incontinence agents S-oxybutynin and terodiline on cardiac K(+) currents and action potentials.

Authors:  S E Jones; L M Shuba; P Zhabyeyev; J R McCullough; T F McDonald
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

2.  The use of oxybutynin in urological practice.

Authors:  Z Kirkali; R H Whitaker
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

3.  The pharmacokinetics of oxybutynin in man.

Authors:  J Douchamps; F Derenne; A Stockis; D Gangji; M Juvent; A Herchuelz
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.